Human glycoprotein-2 expressed in Brunner glands - A putative autoimmune target and link between Crohn's and coeliac disease

Clin Immunol. 2023 Feb:247:109214. doi: 10.1016/j.clim.2022.109214. Epub 2023 Jan 4.

Abstract

Glycoprotein 2 (GP2) is an autoantigen in Crohn's (CD) and coeliac disease (CeD). We assessed GP2-isoform (GP21-4)-expression in intestinal biopsies of paediatric patients with CD, CeD, ulcerative colitis (UC), and healthy children (HC). Transcription of GP21-4 was elevated in proximal small intestine in CeD and CD patients (only GP22/4) compared to jejunum (CeD/CD) and large bowel (CD). CeD patients demonstrated higher duodenal GP22/4-mRNA levels compared to HC/UC patients whereas CD patients showed higher GP24-mRNA levels compared to UC patients. Duodenal synthesis of only small GP2 isoforms (GP23/4) was demonstrated in epithelial cells in patients/HC and in Brunner glands (also large isoforms) with a more frequent apical location in CD/CeD patients. All four GP2 isoforms interacted with gliadin and phosphopeptidomannan. Gliadin digestion improved binding to GP2 isoforms. GP21-4 binding to CeD/CD-related antigens, elevated duodenal GP21-4-mRNA transcription, and GP2-protein secretion in Brunner glands of CeD/CD patients suggest an autoimmune CeD/CD link.

Keywords: Celiac disease; Crohn's disease; Zymogen granule membrane glycoprotein GP2.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Autoantibodies
  • Brunner Glands*
  • Celiac Disease*
  • Child
  • Colitis, Ulcerative* / genetics
  • Crohn Disease* / genetics
  • GPI-Linked Proteins
  • Gliadin
  • Humans
  • Protein Isoforms
  • RNA, Messenger / genetics

Substances

  • Gliadin
  • GPI-Linked Proteins
  • Autoantibodies
  • Protein Isoforms
  • RNA, Messenger